Indegene Limited — Updates, 24-02-2025: Press Release

Indegene has launched Cortex, a Generative AI platform tailored specifically for the life sciences industry. This innovative platform supports leaders in optimizing high-value use cases, enhancing the efficiency and effectiveness of medical writing, and streamlining the content supply chain. By leveraging over 25 years of subject matter expertise, Cortex integrates advanced knowledge graphs and allows configuration with preferred Large Language Models (LLMs). The multi-agent orchestration of Cortex facilitates system integration across the enterprise, offering reliable, quick, and cost-effective outcomes compared to generic platforms. Indegene's leadership emphasizes the importance of security, governance, and scalability, enabling life sciences companies to adopt this transformative technology confidently. Industry analysts have recognized Indegene’s strategic impact in the GenAI space, highlighting its ability to improve health outcomes and optimize costs within the healthcare ecosystem. Investors should watch closely as this platform may position Indegene favorably in a rapidly evolving market.